Member Societies

• All
• Nov. 18 (Thu)
• Nov. 19 (Fri)
• Nov. 20 (Sat)

• KSG
• KSGE
• KASL
• KSNM
• KPBA
• KCHUGR
• KASID
• KSGC
• KSPGHAN
• Joint Session between KDDW-TDDW-JDDW
• Others
• Free Paper
• Satellite Symposium

Free Paper 09 : Lower GI 1 English

Date / Time	Nov. 19 (Fri), 08:30-09:20
Channel	Channel 6
Chair(s)	Kyu Chan Huh (Konyang Univ., Korea) Hyungun Kim (Soonchunhyang Univ., Korea)
Speakers	08:30-08:40	Comparison between CleanViewAL (1L Polyethylene Glycol with Ascorbic Acid, PEG-Asc) and Plenvu (1L PEG-Asc) for Colonoscopic Bowel Preparation: Prospective Randomized Non-Inferiority Study Suh Hyun Choi (Inje Univ. Seoul Paik Hosp., Korea)
	08:40-08:50	Impact of Colonoscopy on Colorectal Cancer Incidence among Persons 40-49 Years Su Young Kim (Yonsei Univ. Wonju, Korea)
	08:50-09:00	Predictive Value of microRNA Level in Normal Tissue Adjacent to the Tumor (NAT) for Prognosis of Colorectal Cancer Patients Lui Ng (The Univ. of Hong Kong, Hong Kong)
	09:00-09:10	A Fecal Immunochemical Test Can Be a New Screening Tool for Dementia: A Nationwide Population-Based Study in Korea Yu Kyung Jun (Seoul National Univ. Hosp., Korea)
	09:10-09:20	The Assessment of Ocimum Sanctum L. Flower Aqueous Extract for Inhibition of Cholesterol Absorption in Human Colorectal Adenocarcinoma (Caco-2) Cells Jakkapong Inchai (Chiangmai Univ., Jakkapong Inchai, Thailand)

Free Paper 10 : Lower GI 2 English

Date / Time	Nov. 19 (Fri), 09:20-10:00
Channel	Channel 6
Chair(s)	Sang Wook Kim (Jeonbuk National Univ., Korea) Ja Seol Koo (Korea Univ., Korea)
Speakers	09:20-09:30	Identification of Optimal Cut-Off Value about Clinical, Chemical and Endoscopic Remission in Korean Inflammatory Bowel Disease Patients through Proactive Therapeutic Drug Level Monitoring of Infliximab Joo Hye Song (Samsung Medical Center, Korea)
	09:30-09:40	Comparison between Proactive and Reactive Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease Who Treated Infliximab Joo Hye Song (Samsung Medical Center, Korea)
	09:40-09:50	IBD Associated Surveillance Dysplasia Program: New Integrated Model - Royal Brisbane Hospital Update Year 1: Audit, Summary, Future Directions and Literature Review Irwin Kashani (Royal Brisbane Hosp., Australia)
	09:50-10:00	Correlation of Total Cholesterol and Gut Damage Status after Intervention of Synbiotic Drink of Stelechocarpus Burahol with Lactobacillus Casei and Lactobacillus Plantarum Isolates: A Dyslipidemic Rats Model Study Alfian Novanda Yosanto (Universitas Islam Indonesia, Indonesia)

Free Paper 11 : Upper GI 1 English

Date / Time	Nov. 19 (Fri), 10:15-10:55
Channel	Channel 6
Chair(s)	Jung Hwan Oh (The Catholic Univ. of Korea, Korea) Sun-Young Lee (Konkuk Univ., Korea)
Speakers	10:15-10:25	Changes in Gut Virome after Helicobacter Pylori Eradication Lingling Wang (The Univ. of Hong Kong, Hong Kong)
	10:25-10:35	Bacteria-Derived Extracellular Vesicles in Urine as a Novel Biomarker for Gastric Cancer: Integration of Liquid Biopsy and Metagenome Analysis Jae Yong Park (Chung-Ang Univ., Korea)
	10:35-10:45	A Randomized Controlled Trial to Compare Helicobacter Pylori Eradication Rates between the Empirical Concomitant and Tailored Therapy Based on 23S rRNA Point Mutation Sujin Kim (Pusan National Univ. Yangsan Hosp., Korea)
	10:45-10:55	Optimal Timing of H. Pylori Eradication after Endoscopic Submucosal Dissection of Gastric Neoplasm; A Multicenter Prospective, Randomized, Controlled Study Cheal Wung Huh (Yongin Severance Hosp., Korea)

Free Paper 12 : Upper GI 2 Korean

Date / Time	Nov. 19 (Fri), 10:55-11:45
Channel	Channel 6
Chair(s)	Hang Lak Lee (Hanyang Univ., Korea) Moon Kyung Joo (Korea Univ., Korea)
Speakers	10:55-11:05	Sex and Age Differences in Histology, Staging, and Survival in 14,861 Patients with Gastric Cancer Hyeong Ho Jo (Seoul National Univ. Bundang Hosp., Korea)
	11:05-11:15	Epstein-Barr Virus but Not Helicobacter Pylori Infection Affects the Clinical Outcome of Gastric Carcinoma Jin Hee Noh (Asan Medical Center, Korea)
	11:15-11:25	Visceral Fat Proportion and Sarcopenia Are Associated with Increased Risk of Early Gastric Neoplasia Dong-Won Ahn (Seoul National Univ. Boramae Medical Center, Korea)
	11:25-11:35	Mutational Landscape of Early Gastric Cancer with Pre-Existing Adenoma Based on Whole Exome Sequencing Bokyung Kim (Seoul National Univ. Hosp., Korea)
	11:35-11:45	Risk Factors of Lymph Node Metastasis in Undifferentiated Early Gastric Cancer Meeting the Criteria for the Expanded Indication for Endoscopic Submucosal Dissection Jiyoung Yoon (Uijeongbu Eulji Medical Center, Eulji Univ., Korea)

Plenary Session English

Date / Time	Nov. 19 (Fri), 12:25-13:55
Channel	Channel 6
Chair(s)	Jae J. Kim (Sungkyunkwan Univ., Korea) Han Chu Lee (Univ. of Ulsan, Korea) Joo Young Cho (CHA Univ., Korea)
Speakers	12:25-12:40	Prevalence and Trends of Multiple Antimicrobial Resistance of H. Pylori in Korea Jung Won Lee (Sungkyunkwan Univ., Samsung Changwon Hosp., Korea)
	12:40-12:55	Clinical Efficacy of Cine MR in the Assessment of Small Bowel Motility: A Dynamic Evaluation for Patients with Megacolon Kyuwon Kim (Univ. of Ulsan College of Medicine, Asan Medical Center, Korea)
	12:55-13:10	Clinical Outcomes and Validation of GLOBE, UK-PBC and UDCA Response Score in Korean Patients with PBC Jong-In Chang (Samsung Medical Center, Sungkyunkwan Univ. School of Medicine, Korea)
	13:10-13:25	Combination Corticosteroids with 5-Aminosalicylic Acids versus Corticosteroids Alone in the Treatment of Hospitalized Patients with Acute Severe Ulcerative Colitis: A Multicenter Randomized Controlled Trial Jae Hee Cheon (Yonsei Univ., Korea)
	13:25-13:40	Preclinical Evaluation of Endoscopic Placement of Steroid-Eluting Metal Stent in an in Vivo Porcine Benign Biliary Stricture Model Sung Ill Jang (Yonsei Univ., Korea)
	13:40-13:55	Synthetic Lethal Targeting of Colorectal Cancer by Drug Loaded Customized Polymeric and Superparamagnetic Iron-Oxide Nanoparticles (SPIONS) in CHEK-2 and BLM Genetically Deficient Colorectal Cancer Cells Anas Ahmad (Institute of Nano Science and Technology, India)

Free Paper 13 : Lower GI 3 English

Date / Time	Nov. 19 (Fri), 14:10-15:00
Channel	Channel 6
Chair(s)	Kang-Moon Lee (The Catholic Univ. of Korea, Korea) Won Moon (Kosin Univ., Korea)
Speakers	14:10-14:20	Investigation on the Changes in Fecal Microbiota Composition after Treatment with Exclusive Enteral Nutrition in Newly Diagnosed Korean Children and Adolescents with Crohn's Disease Ben Kang (Kyungpook National Univ., Pediatrics, Korea)
	14:20-14:30	DNA Methylation Profiles Accurately Predict Response to Ustekinumab and Show Stability during Both Induction and Maintenance Treatment in Moderate-Severe Crohns Disease Vincent Joustra (Amsterdam Umc Location Amc, Netherlands)
	14:30-14:40	Predicting Outcomes for Crohns Disease Using a Molecular Biomarker: PROFILE Trial Interim Update Nurulamin Noor (Cambridge Univ. Hosp.s Nhs Trust, United Kingdom)
	14:40-14:50	Are Clinical Decision Support Tools for Vedolizumab and Ustekinumab in Biologic Nave Patients with Crohns Disease Drug-Specific? Ji Eun Kim (Samsung Medical Center, Korea)
	14:50-15:00	Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patient with intestinal Behcet's disease as a marker of disease activity Byung Wook Jung (Yonsei Univ. College of Medicine, Korea)

Free Paper 14 : Lower GI 4 English

Date / Time	Nov. 19 (Fri), 15:00-15:40
Channel	Channel 6
Chair(s)	Yon Ho Choe (Sungkyunkwan Univ., Korea) You Sun Kim (Inje Univ., Korea)
Speakers	15:00-15:10	Changing Performance and Outcome of Colorectal Cancer Screening before and during COVID-19 Pandemic in Korea Hyunil Kim (Wonju Severance Christian Hosp., Korea)
	15:10-15:20	The Changes in Trends of Lower Gastrointestinal Endoscopy Conducted in Children and Adolescents after the COVID-19 Outbreak in Korea Sujin Choi (Kyungpook National Univ. Medical Center, Korea)
	15:20-15:30	The Occurrence of Infection-Related Gastrointestinal Systemic Diseases in Korean Children and Adolescents Has Decreased after the Spread of the COVID-19 Pandemic Sujin Choi (Kyungpook National Univ. Medical Center, Korea)
	15:30-15:40	Free Antibodies-to-Infliximab Is a Superior Biomarker for Predicting Clinical Outcomes and the Effect of Dose Intensification in Crohns Disease Than Total Antibodies-to-Infliximab Eun Sil Kim (Samsung Medical Center, Korea)

Free Paper 15 : Hepatocellular Carcinoma Korean & English

Date / Time	Nov. 19 (Fri), 15:55-16:45
Channel	Channel 6
Chair(s)	Hee Bok Chae (Chungbuk National Univ., Korea) Yoon Jun Kim (Seoul National Univ., Korea)
Speakers	15:55-16:05	Impact of Tumor Size on Outcome of Hepatectomy for Hepatocellular Carcinoma: A Nationwide Propensity Score Adjusted Analysis Suk Kyun Hong (Seoul National Univ. Hosp., Korea)
	16:05-16:15	Long-Term Outcomes of Transarterial Radioembolization for Large Single Hepatocellular Carcinoma: A Comparison to Resection Jihye Kim (Seoul National Univ. College of Medicine, Korea)
	16:15-16:25	Steatosis of Hepatocellular Carcinoma: Association with Underlying Liver Disease and Clinico-Pathological Characteristics Hyungjin Rhee (Severance Hosp., Korea)
	16:25-16:35	The Prognostic Role of Albumin-Bilirubin (ALBI) Grade in Dialysis Patients with Hepatocellular Carcinoma Shu Yein Ho (Min-Sheng General Hosp., Taiwan)
	16:35-16:45	Machine Learning Models in the Prediction of One-Year Mortality in Patients with Advanced Hepatocellular Cancer Treated with Immunotherapy Thomas Ka-Luen Lui (Li Ka Shing Faculty of Medicine, Univ. of Hong Kong, Hong Kong)

Free Paper 16 : Basic Research and Drug Induced Liver Injury Korean & English

Date / Time	Nov. 19 (Fri), 16:45-17:25
Channel	Channel 6
Chair(s)	Jin-Wook Kim (Seoul National Univ. Bundang Hosp., Korea) Won Young Tak (Kyungpook National Univ., Korea)
Speakers	16:45-16:55	RNA-Seq Analysis of Liver from NASH-HCC Model Mouse Treated with Streptozotocin-High Fat Diet Linh Bui Phuong (SMC Laboratories Inc., Japan)
	16:55-17:05	YAP/TAZ Expression in Hepatocellular Carcinoma (HCC) and Effects of YAP/TAZ Inhibition on HCC Sojung Han (Uijeongbu Eulji Medical Center, Eulji Univ., Korea)
	17:05-17:15	Biliary Organoids Engraft and Differentiate Into Functional Hepatocytes in Chronically-Injured Mice Liver Savneet Kaur (Institute of Liver and Biliary Sciences, India)
	17:15-17:25	Etiology and Clinical Characteristics of Drug-Induced Liver Injury and Herbal and Dietary Supplement-Induced Liver Injury in Korea: A Prospective Multicenter Study Chan Young Jeong (Seoul National Univ. Bundang Hosp., Korea)